Cue Biopharma, Inc. (CUE) Free cash flow 2017–2025
Cue Biopharma, Inc. (CUE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$21.9MFY2025 · since FY2017: -$13.2M → -$21.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.9M | +39.9% |
| FY2024 | -$36.4M | +8.9% |
| FY2023 | -$40.0M | +4.8% |
| FY2022 | -$42.0M | -5.6% |
| FY2021 | -$39.8M | -20.1% |
| FY2020 | -$33.1M | -7.3% |
| FY2019 | -$30.8M | -9.1% |
| FY2018 | -$28.3M | -114.6% |
| FY2017 | -$13.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice